Informed consent for schizophrenia research: What is an investigator (or IRB) to do?

Behavioral Sciences and the Law

Volumn 24, Issue 4, 2006, Pages 447-452

  Palmer, Barton W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOETHICS; CLINICAL RESEARCH; COGNITIVE DEFECT; CONFERENCE PAPER; DECISION MAKING; HUMAN; INFORMED CONSENT; MEDICAL RESEARCH; MENTAL DISEASE; SCHIZOPHRENIA;

BIOMEDICAL RESEARCH; HUMANS; INFORMED CONSENT; MENTAL COMPETENCY; SCHIZOPHRENIA; UNITED STATES;

EID: 33748329380     PISSN: 07353936     EISSN: 10990798     Source Type: Journal    
DOI: 10.1002/bsl.695     Document Type: Conference Paper

References (21)

1. Appelbaum, P. S., & Grisso, T. (2001). MacCAT-CR: MacArthur Competence Assessment Tool for Clinical Research. Sarasota, FL: Professional Resource Press.
2. Awad, N., Gagnon, M., & Messier, C. (2004). The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. Journal of Clinical and Experimental Neuropsychology, 26, 1044-1080.
3. Collie A. (2005). Cognition in liver disease. Liver International, 25, 1-8.
4. Dunn, L. B. (2006). Capacity to consent to research in schizophrenia: The expanding evidence base. Behavioral Sciences and the Law, 24, 431-445.
5. Dunn, L. B., & Jeste, D. V. (2001). Enhancing informed consent for research and treatment. Neuropsychopharmacology, 24, 595-607.
6. Dunn, L. B., Lindamer, L. A., Palmer, B. W., Golshan, S., Schneiderman, L. J., & Jeste, D. V. (2002). Improving understanding of research consent in middle-aged and elderly patients with psychotic disorders. American Journal of Geriatric Psychiatry, 10, 142-150.
7. Dunn, L. B., Nowrangi, M. A., Palmer, B. W., Jeste, D. V., & Saks, E. R. (in press). Assessing decisional capacity for clinical research or treatment: A review of instruments. American Journal of Psychiatry.
8. Epstein, L. C., & Lasagna, L. (1969). Obtaining informed consent. Form or substance. Archives of Internal Medicine, 123, 682-688.
9. Heaton, R. K., Grant, I., Butters, N., White, D. A., Kirson, D., Atkinson, J. H., McCutchan, J. A., Taylor, M. J., Kelley, M. D., Ellis, R. D., Wolfson, T., Velin, R., Marcotte, T. D., Hesselink, J. R., Jernigan, T. L., Chandler, J., Wallace, M., Abramson, I., & the HNRC group. (1995). The HNRC 500-Neuropsychology of HIV infection at different stages. Journal of the International Neuropsychological Society, 1, 231-251.
10. Jeste, D. V., Depp, C. A., & Palmer, B. W. (2006). Magnitude of impairment in decisional capacity in people with schizophrenia compared to normal subjects: An overview. Schizophrenia Bulletin, 32(1), 121-128.
11. Karlawish, J. H., & Lantos, J. (1997). Community equipoise and the architecture of clinical research. Cambridge Quarterly Healthcare Ethics, 6, 385-396.
12. Kim, S. Y. H., Appelbaum, P. S., Jeste, D. V., & Olin, J. T. (2004). Proxy and surrogate consent in geriatric neuropsychiatric research: Update and recommendations. American Journal of Psychiatry, 161, 797-806.
13. Moser, D. J., Reese, R. L., Hey, C. T., Schultz, S. K., Arndt, S., Beglinger, L. J., Duff, K. M., & Andreasen, N. C. (2006). Using a brief intervention to improve decisional capacity in schizophrenia research. Schizophrenia Bulletin, 232(1), 116-120.
14. National Bioethics Advisory Commission. (1998). Research Involving Persons with Mental Disorders that may Affect Decisionmaking Capacity: Volume I Report and recommendations of the National Bioethics Advisory Commission. Rockville, MD: Author.
15. Newman, M. F., Kirchner, J. L., Phillips-Bute, B., Gaver, V., Grocott, H., Jones, R. H., Mark, D. B., Reves, J. G., Blumenthal, J. A., Neurological Outcome Research Group, & Cardiothoracic Anesthesiology Research Endeavors Investigators. (2001). Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. New England Journal of Medicine, 8, 395-402.
16. Palmer, B. W., Dunn, L. B., Appelbaum, P. S., & Jeste, D. V. (2004). Correlates of treatment-related decision-making capacity among middle-aged and older patients with schizophrenia. Archives of General Psychiatry, 61, 230-236.
17. Palmer, B. W., Dunn, L. B., Appelbaum, P. S., Mudaliar, S., Thal, L., Henry, R., Golshan, S., & Jeste, D. V. (2005) Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease or diabetes mellitus: Comparison of a three-item questionnaire with a comprehensive standardized capacity instrument. Archives of General Psychiatry, 62, 726-733.
18. Palmer, B. W., Heaton, R. K., Paulsen, J. S., Kuck, J., Braff, D., Harris, M. J., Zisook, S., & Jeste, D. V. (1997). Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology, 11, 437-446.
19. Saykin, A. J., Ahles, T. A., & McDonald, B. C. (2003). Mechanisms of chemotherapy-induced cognitive disorders: Neuropsychological, pathophysiological, and neuroimaging perspectives. Seminars in Clinical Neuropsychiatry, 8, 201-216.
20. Waldstein, S. R., Manuck, S. B., Ryan, C. M., & Muldoon, M. F. (1991). Neuropsychological correlates of hypertension: Review and methodologic considerations. Psychological Bulletin, 110, 451-468.
21. Westervelt, H. J., & McCaffrey, R. J. (2002). Neuropsychological functioning in chronic Lyme disease. Neuropsychology Review, 12, 153-177.